by Annie De Groot | Aug 25, 2020 | Featured, News
PROVIDENCE, RI, August 24, 2020 /PRNewswire/ — EpiVax, Inc. (“EpiVax”), a Rhode Island-based company and recognized leader in the field of computational vaccinology, today announced it has out-licensed its COVID-19 vaccine candidate, EPV-CoV-19, to EpiVax...
by Annie De Groot | Aug 24, 2020 | Featured, Thinking Out Loud -Blog
Time for T? Or Plan B for Operation Warp Speed? Six months ago, we asked if vaccine makers were rushing to “check the box” rather than spending time designing an effective vaccine (here is another link showing ‘how to”). And have you noticed that all of...
by Annie De Groot | Aug 20, 2020 | Events, Featured
With the 2020 TIDES USA Virtual conference right around the corner, we at EpiVax are proud to sponsor this event, as we have year after year. Our CEO and leader in #FearlessScience Dr. Anne De Groot will be presenting a talk on a generic case study New Dogs/Old...
by Annie De Groot | Jul 24, 2020 | News, Thinking Out Loud -Blog
Are we “Checking the Box” or Making Vaccines that work? We need a COVID-19 vaccine! From China to the US to Europe and even Africa, scientists are working tirelessly, if not at “warp speed”, to develop and test more than one COVID-19...
by Annie De Groot | Jun 11, 2020 | Events, Webinars
This webinar has ended, but we invite you to view the recorded recap here. Please join us on July 17, 2020 for our next live webinar, topic TBA! Please extend this invitation to any colleagues or associates you feel would benefit from attending. Participation is...